Screening for Colorectal Cancer: A Guidance Statement From the American College of Physicians
Top Cited Papers
Open Access
- 6 March 2012
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 156 (5), 378-386
- https://doi.org/10.7326/0003-4819-156-5-201203060-00010
Abstract
This article has been corrected. The original version (PDF) is appended to this article as a supplement. Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. The American College of Physicians (ACP) developed this guidance statement for clinicians by assessing the current guidelines developed by other organizations on screening for colorectal cancer. When multiple guidelines are available on a topic or when existing guidelines conflict, ACP believes that it is more valuable to provide clinicians with a rigorous review of the available guidelines rather than develop a new guideline on the same topic. The authors searched the National Guideline Clearinghouse to identify guidelines developed in the United States. Four guidelines met the inclusion criteria: a joint guideline developed by the American Cancer Society, the U.S. Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology and individual guidelines developed by the Institute for Clinical Systems Improvement, the U.S. Preventive Services Task Force, and the American College of Radiology. ACP recommends that clinicians perform individualized assessment of risk for colorectal cancer in all adults. ACP recommends that clinicians screen for colorectal cancer in average-risk adults starting at the age of 50 years and in high-risk adults starting at the age of 40 years or 10 years younger than the age at which the youngest affected relative was diagnosed with colorectal cancer. ACP recommends using a stool-based test, flexible sigmoidoscopy, or optical colonoscopy as a screening test in patients who are at average risk. ACP recommends using optical colonoscopy as a screening test in patients who are at high risk. Clinicians should select the test based on the benefits and harms of the screening test, availability of the screening test, and patient preferences. ACP recommends that clinicians stop screening for colorectal cancer in adults over the age of 75 years or in adults with a life expectancy of less than 10 years.This publication has 12 references indexed in Scilit:
- Overuse of Screening Colonoscopy in the Medicare PopulationArchives of Internal Medicine, 2011
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous SystemJNCI Journal of the National Cancer Institute, 2011
- ACR Appropriateness Criteria® on Colorectal Cancer ScreeningJournal of the American College of Radiology, 2010
- The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of MethodsAnnals of Internal Medicine, 2010
- AGREE II: advancing guideline development, reporting and evaluation in health careCMAJ : Canadian Medical Association Journal, 2010
- American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008The American Journal of Gastroenterology, 2009
- Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2008
- Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology, 2008
- Prospective blinded trial of the colonoscopic miss-rate of large colorectal polypsGastrointestinal Endoscopy, 1991
- Prospective Study of the Frequency and Size Distribution of Polyps Missed by ColonoscopyJNCI Journal of the National Cancer Institute, 1990